03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Gemzar 1g* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Lilly |
Responsible Party | Lilly France SAS |
Origin | France |
Manufacturer | Lilly France SAS |
Origin | France |
ATC | L01BC05 |
Gemzar 1g* :
Gemzar 1g* :
Gemzar 1g* :
Gemzar 1g* :
Gemzar 1g* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Gemzar 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Alopecia | Very Common |
ALT increased | Very Common |
Anaemia | Very Common |
Anaphylactoid reactions | Very rare |
Anorexia | Common |
Arrhythmia | Uncommon |
Arrhythmia supraventricular | Uncommon |
AST increased | Very Common |
Asthenia | Common |
Back pain | Common |
Blisters (Vesicle) | Rare |
Blood bilirubin increased | Common |
Bronchospasm | Uncommon |
Bullous eruption | Rare |
Cardiac failure | Uncommon |
Cephalea | Common |
Cerebrovascular accident | Uncommon |
Chills | Common |
Colitis ischaemic | Very rare |
Constipation | Common |
Cough | Common |
Death | Uncommon |
Desquamation | Rare |
Diarrhoea (Diarrhea) | Common |
Dyspnoea (dyspnea) | Very Common |
Face oedema | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Fever | Common |
Gamma-GT increased | Rare |
Gangrene | Rare |
Haematuria (Hematuria) | Very Common |
Haemolytic uraemic syndrome (HUS) | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Uncommon |
Hepatotoxicity (liver toxicity) | Uncommon |
Hypotension | Rare |
Influenza symptoms | Very Common |
Injection site reaction | Rare |
Insomnia | Common |
Interstitial pneumonitis | Uncommon |
Leucopenia (Leukopenia) | Very Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Mouth ulceration | Common |
Myalgia | Common |
Myocardial infarction | Rare |
Nausea | Very Common |
Neutropenia | Very Common |
Oedema | Very Common |
Oedema peripheral | Very Common |
Peripheral vasodilatation (Peripheral vasculitis) | Rare |
Platelet count decreased (Thrombocyte count decreased) | Very Common |
Proteinuria | Very Common |
Pruritus | Very Common |
Pulmonary oedema | Rare |
Radiation recall syndrome | Rare |
Radiation toxicity | Rare |
Renal insufficiency | Uncommon |
Respiratory distress syndrome | Rare |
Rhinitis | Common |
Skin Eruption | Very Common |
Skin ulcer | Rare |
Somnolence | Common |
Stevens-Johnson syndrome | Very rare |
Stomatitis | Common |
Sweating | Common |
Thrombocythaemia | Very rare |
Vomiting | Very Common |
Gemzar 1g* :
NB : Products With Same Indication |
Different Units By MoH Code
Gemzar 1g* MoH 565 :
Form | Powder for solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | Box of 1 |
Strength | 1g |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 135281 |
Submission date | 01/01/1997 |
Registration Year | 1997 |
Archived Date | 2019 |
Price Comparison
● Country: | Oman | |
● Package Size: | 1 | |
● Public Price: | 111.83 OMR | ( 25,802,983.22 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 111,83 OMR | ( 25,611,474.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 1 | |
● Public Price: | 243.4 EUR | ( 23,579,618.40 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 243,4 EUR | ( 23,540,868.00 LBP ) |
● Exfactory Price: | 110.64 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 1 Vial | |
● Public Price: | 797 QAR | ( 19,572,726.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 797 QAR | ( 19,572,726.00 LBP ) |
● Pharmacy Price: | 654.59 QAR | ( 16075421.22 LBP ) |
● Pricing Date: | 20/07/2017 | |
● Type: | Medicine Non Marketed |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 162.76 GBP | ( 18,497,511.24 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 162,76 GBP | ( 18,411,138.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Abu Dhabi | |
● Package Size: | 1 Vial (Dry) | |
● Public Price: | 744.5 AED | ( 17,987,864.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 744,5 AED | ( 17,975,784.00 LBP ) |
● Pharmacy Price: | 634.26 AED | ( 15324355.86 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 1 Vial (Dry) | |
● Public Price: | 744.5 AED | ( 17,987,864.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 744,5 AED | ( 17,975,784.00 LBP ) |
● Pharmacy Price: | 634.26 AED | ( 15324355.86 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1 | |
● Public Price: | 181.92 EUR | ( 17,623,681.92 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 181,92 EUR | ( 17,534,556.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 01/06/2018 | |
● Type: | Medicine Non Marketed |
● Country: | Switzerland | |
● Package Size: | 1 | |
● Public Price: | 167.75 CHF | ( 17,348,705.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 167,75 CHF | ( 17,271,140.00 LBP ) |
● Exfactory Price: | 131.84 CHF | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Spain | |
● Package Size: | 1 vial | |
● Public Price: | 172.55 EUR | ( 16,715,953.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 172,55 EUR | ( 16,662,672.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Bahrain | |
● Package Size: | 1 | |
● Public Price: | 70.83 BHD | ( 16,838,699.22 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 70,83 BHD | ( 16,641,380.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 18/11/2017 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 1 | |
● Public Price: | 1783.6 NOK | ( 14,454,294.40 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1783,6 NOK | ( 14,449,432.00 LBP ) |
● Pharmacy Price: | 1370.47 NOK | ( 11106288.88 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 03/06/2019 | |
● Type: | Medicine Withdrawn |
● Country: | Czech Republic | |
● Package Size: | 1 | |
● Public Price: | 3363.85 CZK | ( 12,846,543.15 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3363,85 CZK | ( 12,843,297.00 LBP ) |
● Exfactory Price: | 2543.9 CZK | |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 1 | |
● Public Price: | 18859 ISK | ( 12,164,055.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 18859 ISK | ( 12,164,055.00 LBP ) |
● Pharmacy Price: | 12681 ISK | ( 8179245 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 30/01/2018 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 30.51 JOD | ( 3,820,492.71 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 30,51 JOD | ( 3,756,630.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 05/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Portugal |
● Package Size: | 1 |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
● Country: | Denmark |
● Package Size: | 1 |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 19/05/2021 |
● Type: | Medicine Non Marketed |
● Country: | New Zealand |
● Package Size: | 1 inj |
● Exfactory Price: | 349.2 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/01/2019 |
● Type: | Medicine Non Marketed |
● Country: | France |
● Package Size: | 1 |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File